WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BCRX

Based on 2 analysts offering 12 month price targets for Biocryst Pharmaceuticals Inc.
Min Forecast
$10.00+140.38%
Avg Forecast
$11.00+164.42%
Max Forecast
$12.00+188.46%

Should I buy or sell BCRX stock?

Based on 2 analysts offering ratings for Biocryst Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BCRX stock forecasts and price targets.

BCRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2023-11-20

1 of 1

Forecast return on equity

Is BCRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is BCRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BCRX revenue forecast

What is BCRX's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$397.9M+20.08%
Avg 2 year Forecast
$493.5M+48.9%
Avg 3 year Forecast
$595.4M+79.66%
BCRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BCRX revenue growth forecast

How is BCRX forecast to perform vs Biotechnology companies and vs the US market?
Company
21.48%
Industry
37.04%
Market
9.92%
BCRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BCRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BCRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCRX$4.16$11.00+164.42%Strong Buy
SLN$21.62$57.25+164.80%Strong Buy
IMNM$14.26$34.00+138.43%Strong Buy
ALXO$16.87$18.25+8.18%Strong Buy
ARQT$8.59$13.50+57.16%Strong Buy
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Forecast FAQ

Is Biocryst Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BCRX) stock is to Strong Buy BCRX stock.

Out of 2 analysts, 1 (50%) are recommending BCRX as a Strong Buy, 1 (50%) are recommending BCRX as a Buy, 0 (0%) are recommending BCRX as a Hold, 0 (0%) are recommending BCRX as a Sell, and 0 (0%) are recommending BCRX as a Strong Sell.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.

What is BCRX's revenue growth forecast for 2024-2026?

(NASDAQ: BCRX) Biocryst Pharmaceuticals's forecast annual revenue growth rate of 21.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Biocryst Pharmaceuticals's revenue in 2024 is $331,412,000.On average, 5 Wall Street analysts forecast BCRX's revenue for 2024 to be $82,036,333,496, with the lowest BCRX revenue forecast at $81,122,058,561, and the highest BCRX revenue forecast at $83,080,482,886. On average, 5 Wall Street analysts forecast BCRX's revenue for 2025 to be $101,729,423,913, with the lowest BCRX revenue forecast at $98,758,184,987, and the highest BCRX revenue forecast at $105,148,832,786.

In 2026, BCRX is forecast to generate $122,742,080,026 in revenue, with the lowest revenue forecast at $115,625,372,178 and the highest revenue forecast at $134,568,489,153.

What is BCRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BCRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BCRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BCRX price target, the average BCRX price target is $11.00, with the highest BCRX stock price forecast at $12.00 and the lowest BCRX stock price forecast at $10.00.

On average, Wall Street analysts predict that Biocryst Pharmaceuticals's share price could reach $11.00 by Apr 10, 2025. The average Biocryst Pharmaceuticals stock price prediction forecasts a potential upside of 164.42% from the current BCRX share price of $4.16.

What is BCRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BCRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.